Global Urinalysis Market - urine analyzer - Bioway Biological Technology Co.,Ltd
español русский English 中文

location:Home > News > IVD Community

Global Urinalysis Market

Source:Bioway Time:2018-09-20

图片22.jpgCoherent Market Insights has announced the addition of the “Global Urinalysis Market Size Status and Forecast 2026”, The report classifies the global Urinalysis Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

North America is the largest region in the urinalysis market. The major driver for the large market share includes presence of key market players in the region such as Alere, Inc., Bio Rad, ,andBeckman Coulter.  Asia Pacific is expected to observe the fastest growth during the forecast period. Increasing penetration rate of advanced urine analyzers, and the presence of local urine analyzer manufacturers, such as ,
Urit medical, and a large base of the target population with unmet clinical needs are expected to strengthen the market growth over the forecast period.

Key players operating in the urinalysis market are Alere, Bio Rad, Roche Diagnostics, Bioway, Arkray, Inc., Sysmex, and Siemens Healthcare.

A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems. A urine test includes three parts namely, visual exam, microscopic exam, and dipstick test. Its primary aim is to screen health conditions. The urinalysis is carried out as routine medical checkup, pregnancy check-up, pre-surgery preparation, or on hospital admission to treat various disorders. It may be used to screen for and/or help diagnose conditions such as a kidney disorders, urinary tract infections, liver problems, diabetes or other metabolic conditions, to name a few. Additional tests and clinical valuation are often required to further examine findings of urinalysis and finally diagnose the causes or specific features of core problems. For example, urine infection is generally identified based on results of urinalysis. Urine culture is frequently ordered as a follow-up test to recognize the bacteria that may be causing the infection.

Urinalysis Market

On the basis of product type, the urinalysis market is classified into the following:

On the basis of test type, the urinalysis market is classified into following:
-Biochemical Urinalysis
-Sediment Urinalysis

On the basis of end user, the urinalysis market is classified into following:
-Diagnostics Laboratories
-Research Laboratories and Institutes
-Home-care Settings
-Urinalysis Market Dynamics

According to Centers for Disease Control and Prevention (CDC), diabetes is one of the most common chronic diseases among humans, around 29.1 million people or 9.3% of the U.S population suffers from diabetes (2016). Increase in the prevalence of chronic diseases and geriatric population will give rise to prevention and cure for the chronic diseases, owing to the growth of urinalysis market. Emergence of portable and battery operated urinalysis devices and increase in implementation of urinalysis in emerging economic countries such as China, India and others, will create new opportunities for the urinalysis market.

 Bioway Biotechnology includes Bioway Biotechnology Co., Ltd. and Yantai Bioway Biological Technology Co., Ltd. The company was founded in 1999 and specializes in R&D and production of urinalysis products. Since the establishment, the company has been committed to the research, development, production and sales of clinical diagnostic products. The main products are urine sediment analysis system, urine analyzer, urine test strip, and urine sediment analysis reagent. All products have independent core technologies and have registered a number of patents in China.

Contact Us:  Email: